
### [MONDO:0015483](http://purl.obolibrary.org/obo/MONDO_0015483)
**Label:** mandibulofacial dysostosis

**Subclasses:** [MONDO:0007944](http://purl.obolibrary.org/obo/MONDO_0007944) (Treacher-Collins syndrome 1), [MONDO:0010539](http://purl.obolibrary.org/obo/MONDO_0010539) (X-linked mandibulofacial dysostosis), [MONDO:0011255](http://purl.obolibrary.org/obo/MONDO_0011255) (mandibulofacial dysostosis-macroblepharon-macrostomia syndrome), [MONDO:0019797](http://purl.obolibrary.org/obo/MONDO_0019797) (acrodysostosis), [MONDO:0014608](http://purl.obolibrary.org/obo/MONDO_0014608) (mandibulofacial dysostosis with alopecia), [MONDO:0013385](http://purl.obolibrary.org/obo/MONDO_0013385) (Treacher Collins syndrome 2), [MONDO:0017240](http://purl.obolibrary.org/obo/MONDO_0017240) (acrodysostosis with multiple hormone resistance), [MONDO:0007044](http://purl.obolibrary.org/obo/MONDO_0007044) (acrodysostosis 1 with or without hormone resistance), [MONDO:0002457](http://purl.obolibrary.org/obo/MONDO_0002457) (Treacher-Collins syndrome), [MONDO:0009558](http://purl.obolibrary.org/obo/MONDO_0009558) (Treacher Collins syndrome 3), [MONDO:0013822](http://purl.obolibrary.org/obo/MONDO_0013822) (acrodysostosis 2 with or without hormone resistance), 

**Mapped go classes:** [GO:0008140](http://purl.obolibrary.org/obo/GO_0008140) (cAMP response element binding protein binding), [GO:0045762](http://purl.obolibrary.org/obo/GO_0045762) (positive regulation of adenylate cyclase activity), [GO:0005952](http://purl.obolibrary.org/obo/GO_0005952) (cAMP-dependent protein kinase complex), [GO:0004862](http://purl.obolibrary.org/obo/GO_0004862) (cAMP-dependent protein kinase inhibitor activity), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0045859](http://purl.obolibrary.org/obo/GO_0045859) (regulation of protein kinase activity), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0004115](http://purl.obolibrary.org/obo/GO_0004115) (3',5'-cyclic-AMP phosphodiesterase activity), [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0003899](http://purl.obolibrary.org/obo/GO_0003899) (DNA-directed 5'-3' RNA polymerase activity), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0001042](http://purl.obolibrary.org/obo/GO_0001042) (RNA polymerase I core binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0042790](http://purl.obolibrary.org/obo/GO_0042790) (transcription of nucleolar large rRNA by RNA polymerase I), [GO:0032793](http://purl.obolibrary.org/obo/GO_0032793) (positive regulation of CREB transcription factor activity), [GO:0014029](http://purl.obolibrary.org/obo/GO_0014029) (neural crest formation), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0005891](http://purl.obolibrary.org/obo/GO_0005891) (voltage-gated calcium channel complex), [GO:0042310](http://purl.obolibrary.org/obo/GO_0042310) (vasoconstriction), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0008603](http://purl.obolibrary.org/obo/GO_0008603) (cAMP-dependent protein kinase regulator activity), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0097271](http://purl.obolibrary.org/obo/GO_0097271) (protein localization to bud neck), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:0004962](http://purl.obolibrary.org/obo/GO_0004962) (endothelin receptor activity), [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme), [GO:0001772](http://purl.obolibrary.org/obo/GO_0001772) (immunological synapse), [GO:0006417](http://purl.obolibrary.org/obo/GO_0006417) (regulation of translation), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0001056](http://purl.obolibrary.org/obo/GO_0001056) (RNA polymerase III activity), [GO:0001054](http://purl.obolibrary.org/obo/GO_0001054) (RNA polymerase I activity), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0008081](http://purl.obolibrary.org/obo/GO_0008081) (phosphoric diester hydrolase activity), [GO:0010155](http://purl.obolibrary.org/obo/GO_0010155) (regulation of proton transport), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure), [GO:0005666](http://purl.obolibrary.org/obo/GO_0005666) (DNA-directed RNA polymerase III complex), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005736](http://purl.obolibrary.org/obo/GO_0005736) (DNA-directed RNA polymerase I complex), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001932](http://purl.obolibrary.org/obo/GO_0001932) (regulation of protein phosphorylation), [GO:0003319](http://purl.obolibrary.org/obo/GO_0003319) (cardioblast migration to the midline involved in heart rudiment formation), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding), [GO:0071901](http://purl.obolibrary.org/obo/GO_0071901) (negative regulation of protein serine/threonine kinase activity), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0019933](http://purl.obolibrary.org/obo/GO_0019933) (cAMP-mediated signaling), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.32%
- [GO:0005952](http://purl.obolibrary.org/obo/GO_0005952) (cAMP-dependent protein kinase complex) 51.85%
- [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme) 51.85%
- [GO:0005736](http://purl.obolibrary.org/obo/GO_0005736) (DNA-directed RNA polymerase I complex) 51.85%
- [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus) 51.85%
- [GO:0005666](http://purl.obolibrary.org/obo/GO_0005666) (DNA-directed RNA polymerase III complex) 51.85%
- [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular) 51.85%
- [GO:0001772](http://purl.obolibrary.org/obo/GO_0001772) (immunological synapse) 51.85%
- [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center) 51.85%
- [GO:0044452](http://purl.obolibrary.org/obo/GO_0044452) (nucleolar part) and [GO:0055029](http://purl.obolibrary.org/obo/GO_0055029) (nuclear DNA-directed RNA polymerase complex) 51.85%
- [GO:0030880](http://purl.obolibrary.org/obo/GO_0030880) (RNA polymerase complex) and [GO:0044452](http://purl.obolibrary.org/obo/GO_0044452) (nucleolar part) 51.85%
- [GO:0000428](http://purl.obolibrary.org/obo/GO_0000428) (DNA-directed RNA polymerase complex) and [GO:0044452](http://purl.obolibrary.org/obo/GO_0044452) (nucleolar part) 51.85%
- [GO:0055029](http://purl.obolibrary.org/obo/GO_0055029) (nuclear DNA-directed RNA polymerase complex) 39.06%
- [GO:0030880](http://purl.obolibrary.org/obo/GO_0030880) (RNA polymerase complex) 39.06%
- [GO:0000428](http://purl.obolibrary.org/obo/GO_0000428) (DNA-directed RNA polymerase complex) 39.06%


